English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Buerger's disease or thromboangiitis obliterans, is a non-atherosclerotic inflammatory process which mostly involves medium and small sized arteries and veins in lower and upper extremities. It is categorized as vasculitis. The disease is known to be closely linked to smoking. Buerger's disease is a long-term debilitating condition because of the pain, the development of ulcers and gangrene, and the risk of amputation. Drugs effective on erythrocyte flexibility, agents acting on platelets, non-steroidal anti-inflammatory drugs and vascular reconstruction are among several therapeutic methods for Buerger's disease. However, the applied therapies are insufficiently effective. Still, the base of treatment is smoking cessation. Lately, cell therapy has offered us entirely new possibilities. Mesenchymal stem cell (MSC) treatment has been proposed as a novel approach for tissue engineering and regenerative medicine for various ischemic disorders, including Buerger's disease. In 2016, the first MSC based therapy has received regulatory approval for the treatment of Buerger's disease in India. In March 2017, orphan designation was granted by the European Commission for autologous adipose tissue-derived MSC for the treatment of Buerger's disease. Novel therapeutic approach needs to be validated in the upcoming studies conducted in different clinical centers.

Advancements in mesenchymal stem cell treatment for Buerger's disease